Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant

British Journal of Haematology

Volumn 103, Issue 4, 1998, Pages 1045-1050

  Simioni, Paolo ^b   Tormene, Daniela ^b   Manfrin, Davide ^b   Gavasso, Sabrina ^b   Luni, Sonia ^b   Stocco, Domenico ^b   Girolami, Antonio ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b NONE

Author keywords

20210A variant; Antigen level; Prothrombin; Thrombophilia

Indexed keywords

PROTHROMBIN;

ANTIGEN DETECTION; ARTICLE; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; THROMBOPHILIA; VEIN THROMBOSIS;

ADULT; ANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTHROMBIN; THROMBOPHILIA;

EID: 0032440472     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01112.x     Document Type: Article

References (16)

1. Arruda, V.R., Annichino-Bizzacchi, J.M., Goncalves, M.S. & Costa, F.F. (1997) Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thrombosis and Haemostasis, 78, 1430-1433.
2. Bloem, B.R., van Putten, M.J., van der Meer, F.J., van Hilten, J.J. & Bertina, R.M. (1998) Superior sagittal sinus thrombosis in a patient heterozygous for the novel 20210A allele of the prothrombin gene. Thrombosis and Haemostasis, 79, 235.
3. Brown, K., Luddington, R., Williamson, D., Baker, P. & Baglin, T. (1997) Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. British Journal of Haematology, 98, 907-909.
4. Bucciarelli, P., Franchi, F., Alatri, A., Bettini, P. & Moia, M. (1998) Budd-Chiari syndrome in a patient heterozygous for the G20210A mutation of the prothrombin gene. Thrombosis and Haemostasis, 79, 445-446.
5. Cumming, A.M., Keeney, S., Salden, A., Bhavnani, M., Shwe, K.H. & Hay, C.R. (1997) The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population. British Journal of Haematology, 98, 353-355.
6. Ferraresi, P., Marchetti, G., Legnani, C., Cavallari, E., Castoldi, E., Mascoli, F., Ardissino, D., Palareti, G. & Bernardi, F. (1997) The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 2418-2422.
7. Friederich, P.W., Sanson, B.-J., Simioni, P., Zanardi, S., Huisman, M.V., Kindt, I., Prandoni, P., Buller, H.R., Girolami, A. & Prins, M.H. (1996) Frequency of pregnancy-related venous thrombo-embolism in anticoagulant factor-deficient women: implications for prophylaxis. Annals of Internal Medicine, 125, 955-960.
8. Hillarp, A., Zoller, B., Svensson, P.J. & Dahlback, B. (1997) The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thrombosis and Haemostasis, 78, 990-992.
9. Howard, T.E., Marusa, M., Channell, C. & Duncan, A. (1997) A patient homozygous for a mutation in the prothrombin gene 3′-untranslated region associated with massive thrombosis. Blood Coagulation and Fibrinolysis, 8, 316-319.
10. Kapur, R.K., Mills, L.A., Spitzer, S.G. & Hultin, M.B. (1997) A prothrombin gene mutation is significantly associated with venous thrombosis. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 2875-2879.
11. Makris, M., Preston, F.E., Beauchamp, N.J., Cooper, P.C., Daly, M.E., Hampton, K.K., Bayliss, P., Peake, I.R. & Miller, G.J., (1997) Coinheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thrombosis and Haemostasis, 78, 1426-1429.
12. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
13. Rosendaal, F.R., Doggen, C.J.M., Zivelin, A., Arruda, V.R., Aiach, M., Siscovick, D.S., Hillarp, A., Watzke, H.H., Bernardi, F., Cumming, A.M., Preston, F.E. & Reitsma, P.H. (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and Haemostasis, 79, 706-708.
14. Simioni, P., Kalafatis, M., Millar, D.S., Henderson, S.C., Luni, S., Cooper, D.N. & Girolami, A. (1996a) Compound heterozygous protein C deficiency resulting in the presence of only the beta form of protein C in plasma. Blood, 88, 2101-2108.
15. Simioni, P., Prandoni, P., Zanon, E., Saracino, M.A., Scudeller, A., Villalta, S., Scarano, L., Girolami, B., Benedetti, L. & Girolami, A. (1996b) Deep venous thrombosis and lupus anticoagulant: a case-control study. Thrombosis and Haemostasis, 76, 187-189.
16. Simioni, P., Scudeller, A., Radossi, P., Gavasso, S., Girolami, B., Tormene, D. & Girolami, A. (1996c) Pseudo-homozygous activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Thrombosis and Haemostasis, 75, 422-426.